SERA PROGNOSTICS, INC. Revenue Breakdown
No Revenue Breakdown for SERA on this site yet.
- 2025-12-31: Total revenue $81.00K.
- 2024-12-31: Total revenue $77.00K.
- 2023-12-31: Total revenue $306.00K.
- 2022-12-31: Total revenue $268.00K.
Source checked: the stored Revenue Breakdown page for SERA.
Revenue by product
Each year (12 month)
| Fiscal year end | Total revenue |
|---|---|
| 2025-12-31 | $81.00K |
| 2024-12-31 | $77.00K |
| 2023-12-31 | $306.00K |
| 2022-12-31 | $268.00K |
| 2021-12-31 | $82.00K |
| 2020-12-31 | $25.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $30.00K 100.00% | $30.00K |
| 2026-03-31 | Not split by product $14.00K 100.00% | $14.00K |
| 2025-12-31 | Not split by product $10.00K 100.00% | $10.00K |
| 2025-09-30 | Not split by product $16.00K 100.00% | $16.00K |
| 2025-06-30 | Not split by product $17.00K 100.00% | $17.00K |
| 2025-03-31 | Not split by product $38.00K 100.00% | $38.00K |
| 2024-12-31 | Not split by product $24.00K 100.00% | $24.00K |
| 2024-09-30 | Not split by product $29.00K 100.00% | $29.00K |
| 2024-06-30 | Not split by product $24.00K 100.00% | $24.00K |
| 2024-03-31 | Not split by product $0.00 | $0.00 |
| 2023-12-31 | Not split by product $41.00K 100.00% | $41.00K |
| 2023-09-30 | Not split by product $42.00K 100.00% | $42.00K |
| 2023-06-30 | Not split by product $123.00K 100.00% | $123.00K |
| 2023-03-31 | Not split by product $100.00K 100.00% | $100.00K |
| 2022-12-31 | Not split by product $65.00K 100.00% | $65.00K |
| 2022-09-30 | Not split by product $87.00K 100.00% | $87.00K |
| 2022-06-30 | Not split by product $78.00K 100.00% | $78.00K |
| 2022-03-31 | Not split by product $38.00K 100.00% | $38.00K |
| 2021-12-31 | Not split by product $26.00K 100.00% | $26.00K |
| 2021-09-30 | Not split by product $23.00K 100.00% | $23.00K |
| 2021-06-30 | Not split by product $20.00K 100.00% | $20.00K |
| 2021-03-31 | Not split by product $13.00K 100.00% | $13.00K |
| 2020-12-31 | Not split by product $6.00K 100.00% | $6.00K |
| 2020-09-30 | Not split by product $5.00K 100.00% | $5.00K |
| 2020-06-30 | Not split by product $6.00K 100.00% | $6.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |